Skip to content

The use of ultrasound in hand osteoarthritis

The use of ultrasound in hand osteoarthritis - ECHO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30978
Enrollment
50
Registered
2008-01-21
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Men or Women with hand osteoarthritis (according to ACR criteria) Older then 45 years Pain score 30 or more on VAS or visual analog function subscale of 225 or more of AUSCAN

Exclusion criteria

Exclusion criteria: Concomitant rheumatic disease Cutaneous psoriasis Underlying disease known to cause OA Rheumatoid factor or anti CCP antibody level above reference level Intra articular injection of one of the hand joints with corticosteroids or oral corticosteroid use less then 1 month prior to investigation

Design outcomes

Primary

MeasureTime frame
All hand joints will be studied on pain, swelling and loss of function. All joints will be scored using ultrasound on whether signs of inflammation are present or not. Analysis of the outcome measures of ultrasound findings of all painful hand joints will be compared to the outcome measures of non painful hand joints. Correction of patient characteristics will take place. A subanalysis will be performed within every patient. The outcome measures of the most painful joint (index joint) will be compared to a non painful osteoarthritic joint the contralateral hand preferably in the same joint or in the same row.

Secondary

MeasureTime frame
Secundary study parameters will be a semi-quantative score on inflammation (0 to 3) using ultrasound of each hand joint. This might give relevant and more detailed information, but reliability of outcome measures might diminish. Also x-ray findings will be compared to clinical signs and ultrasound findings.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)